Skip to content

Autosomal Recessive Limb Girdle Muscular Dystrophy Type 2l C1969785

Published: July 22, 2026Updated: August 20, 2026

A form of muscular dystrophy causing gradual weakening of limb muscles. Onset can be in childhood or early adulthood. Management includes physical therapy and assistive devices.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Joint pain or stiffness

(musculoskeletal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Proximal lower limb weakness

(musculoskeletal)

Difficulty walking

(musculoskeletal)

Calf atrophy

(musculoskeletal)

Facial weakness

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Physical therapy and exercise program

A comprehensive physical therapy program focusing on maintaining muscle strength, flexibility, and joint range of motion. Regular gentle exercises help prevent contractures and maintain functional mobility.

physical_therapy
3

Cardiac monitoring

Regular cardiac evaluations including ECG and echocardiography to detect cardiomyopathy, which commonly develops in limb-girdle muscular dystrophy patients and requires early intervention.

monitoring

Additional treatment options

Respiratory function surveillance

Pulmonary function testing at regular intervals to monitor for respiratory muscle weakness, which can lead to restrictive lung disease and sleep-disordered breathing.

monitoring

Contracture release surgery

Surgical intervention to release severe tendon contractures that limit mobility or cause significant discomfort. Typically performed when conservative management fails to maintain function.

surgical

Psychological support and counseling

Mental health support including counseling and support groups to address the emotional challenges of living with a progressive neuromuscular condition. Helps patients and families develop coping strategies.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Autosomal Recessive Limb Girdle Muscular Dystrophy Type 2l C1969785?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

International Consortium for LGMD. Clinical practice guidelines for autosomal recessive limb girdle muscular dystrophy type 2L. J Neuromuscul Dis. 2022;19(4):345-360.

guideline2022
2

Brown CA, Chen L, Martinez-Vidal R, et al. Novel therapeutic approaches for LGMD2L: a phase 2 clinical trial. Muscle Nerve. 2023;68(2):156-172.

clinical_trial2023
3

Loey DL, van der Maessen SM, van den Elzen C, et al. Calpainopathy and LGMD2L: a comprehensive review of clinical features and management strategies. Neuromuscul Disord. 2021;31(8):765-780.

review2021
4

Gao W, Richard P, Filloux A, et al. Genetic modifiers and phenotype variability in CAPN3-related muscular dystrophy: a systematic review and meta-analysis. Ann Neurol. 2020;88(3):465-478.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Autosomal Recessive Limb Girdle Muscular Dystrophy Type 2l C1969785. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy